Publications
Specialty
Search
ePlasty, Surgery
06/07/2024
Hyperbaric oxygen therapy use in treatment of necrotizing soft tissue infection extending from the buttocks and perineum down to the left lower limb.
Dermatology
06/07/2024
Researchers aimed to evaluate serum levels of inflammatory cytokines, specifically tumor necrosis factor-alpha and IL-17, in patients with nail psoriasis.
Oncology
06/07/2024
Cilta-cel improved outcomes for patients with lenalidomide-refractory functional high-risk multiple myeloma vs standard of care, according to data presented by Luciano Costa, MD, at the 2024 ASCO Annual Meeting.
The Dermatologist
06/07/2024
A 48-year-old man presented with a progressively enlarging tumor on his right wrist.
The Dermatologist
06/07/2024
The contents of these questions are taken from the Galderma Pre-Board Webinar. The Pre-Board Webinar is now an online course. For details, go to https://www.galderma.com/us/preboard-webinar.
Oncology
06/07/2024
Maria-Victoria Mateos, MD, PhD, presents results from the phase 3 DREAMM-7 trial, which demonstrated the efficacy of belantamab mafodotin plus bortezomib and dexamethasone as a potential new standard of care for patients with R/R MM.
Vascular Disease Management, Journal of Invasive Cardiology, CardioVascular
06/07/2024
HOUMA, LA – Dr. Matthew Finn, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in Louisiana to use the VenaCore™ thrombectomy catheter to remove challenging venous occlusions in patients suffering from long-term complications of deep vein thrombosis (DVT). The procedure was performed in the cath lab at Terrebonne General Health.
Oncology
06/07/2024
Rebecca Shatsky, MD, shares results on datopotamab deruxtecan plus durvalumab for certain patients with advanced breast cancer from the I-SPY2.2 trial.
Oncology
06/07/2024
According to updated survival results from the DESTINY-Breast03 trial, trastuzumab deruxtecan continues to show superiority over trastuzumab emtansine among patients with HER2-positive metastatic breast cancer.
The Dermatologist, Dermatology
06/06/2024
Dr Arash Mostaghimi discusses innovative approaches for meaningful hair regrowth and the role of patient advocacy in supporting those affected by this autoimmune disease.
The Dermatologist
06/06/2024
New onset of pruritus and weight loss in a healthy young person should prompt an investigation for underlying causes of itch.
EP Lab Digest
06/06/2024
Risk of bleeding highest in first three months of treatment, even in patients on low doses of direct oral anticoagulants
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
06/06/2024
“This document provides for the first time a standardization on nomenclature for quantitative parameters derived from CCTA,” said Hector Garcia-Garcia, MD, PhD. “It marks a turning point in reporting of CCTA as it focuses on actual quantification of atherosclerosis.”
Pharmacy Learning Network
06/06/2024
In this week's installment of Talking Therapeutics, Dr Jennings explores a new trial that evaluates the impact of GLP-1 agonists on kidney and cardiovascular endpoints in patients with diabetes and chronic kidney disease.
The Dermatologist
06/06/2024
This rare condition is characterized by the excretion of colorless sweat that later becomes colored upon contact with external causes such as clothing or environmental factors.
Annals of Long-Term Care
06/06/2024
The US Food and Drug Administration (FDA) granted the investigational cell therapy bemdaneprocel a Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of Parkinson disease (PD), announced bemdaneprocel developer BlueRock Therapeutics, a subsidiary of Bayer AG.
The Dermatologist
06/06/2024
Keep these tips and pearls from dermatologic experts in mind for your next appointment.
First Report Managed Care
06/06/2024
In this interview, Alison Lum, PharmD, vice president of Pharmacy Services at Blue Shield, discussed the panel she moderated at Asembia 2024 and delved into drug payment options' challenges, including the limitations of copay cards and the need for transparent pricing models.